These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 851115)

  • 21. [Change in the pharmacokinetics of drug substances in kidney diseases].
    Kudrin AN; Davydova ON; Androsova SO
    Klin Med (Mosk); 1980 May; 58(5):13-6. PubMed ID: 6991802
    [No Abstract]   [Full Text] [Related]  

  • 22. Antipyrine kinetics in Nigerian women in chronic renal failure.
    Iyun AO; Tucker GT
    Afr J Med Med Sci; 1982 Mar; 11(1):7-9. PubMed ID: 6291357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.
    Drayer DE
    Clin Pharmacokinet; 1976; 1(6):426-43. PubMed ID: 799549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics in renal failure.
    Nancarrow C; Mather LE
    Anaesth Intensive Care; 1983 Nov; 11(4):350-60. PubMed ID: 6359952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal function and therapeutic concentrations of phenytoin.
    Liponi DF; Winter ME; Tozer TN
    Neurology; 1984 Mar; 34(3):395-7. PubMed ID: 6538287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Active drug metabolites and renal failure.
    Drayer DE
    Am J Med; 1977 Apr; 62(4):486-9. PubMed ID: 851118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Plasma binding of drugs in chronic renal failure].
    Riant P; Barre J; Albengres E; Lemaire M; Tillement JP
    Nephrologie; 1986; 7(3):89-93. PubMed ID: 3774085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of clofibrate in patients with renal insufficiency.
    Viikari J; Anttila M; Kasanen A
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):77-80. PubMed ID: 6840929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics in the elderly.
    Crooks J; O'Malley K; Stevenson IH
    Clin Pharmacokinet; 1976; 1(4):280-96. PubMed ID: 797500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered nonrenal drug clearance in ESRD.
    Nolin TD
    Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):555-9. PubMed ID: 18941346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of binding in distribution of furosemide: where is nonrenal clearance?
    Branch RA
    Fed Proc; 1983 Apr; 42(6):1699-702. PubMed ID: 6832389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical relevance of impaired nonrenal drug clearance in ESRD.
    Nolin TD; Unruh ML
    Semin Dial; 2010; 23(5):482-5. PubMed ID: 21069923
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pharmacokinetics in renal insufficiency].
    Twardowski Z; Ksiazek A
    Pol Arch Med Wewn; 1981 Jun; 65(6):491-500. PubMed ID: 7022395
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on digitalis. VII. Influence of nephrotic syndrome on protein binding, pharmacokinetics, and renal excretion of digitoxin and cardioactive metabolites.
    Storstein L
    Clin Pharmacol Ther; 1976 Aug; 20(2):158-66. PubMed ID: 947651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study.
    Lal R; Sukbuntherng J; Luo W; Chen D; Blumenthal R; Ho J; Cundy KC
    Clin Ther; 2012 Jan; 34(1):201-13. PubMed ID: 22206794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug dosing adjustments in patients with chronic kidney disease.
    Munar MY; Singh H
    Am Fam Physician; 2007 May; 75(10):1487-96. PubMed ID: 17555141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nomogram for drug dosage adjustment in patients with renal failure.
    Bjornsson TD
    Clin Pharmacokinet; 1986; 11(2):164-70. PubMed ID: 3956049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drug therapy in renal failure].
    Lachhein L
    Z Gesamte Inn Med; 1980 Aug; 35(15):Suppl 38-40. PubMed ID: 7467564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A computer program for the drug dosage of patients with chronic kidney failure].
    Krivoshiev S; Kalaĭdzhiev Zh; Antonov S; Zlatarska S; Kiriakov Z
    Khirurgiia (Sofiia); 1989; 42(5):108-10. PubMed ID: 2625912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.